• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Sara Tolaney, MD, MPH


  • Garber JE, Halabi S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge S, Shapiro CL, Dressler L, Paskett ED, Paskett EM, Kimmick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N, .Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.Journal of the National Cancer Institute. 2010 Jul 7;102(13):942-9.
  • Tolaney SM,Krop IE.Mechanisms of trastuzumab resistance in breast cancer.Anticancer Agents Med Chem. 2009 Mar;9(3):348-55. Review.
  • Tolaney SM,Najita J,Winer EP,Burstein HJ.Lymphopenia associated with adjuvant anthracycline/ taxane regimens.Clin Breast Cancer. 2008 Aug;8(4):352-6.
  • Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EP.Sarcoidosis mimicking metastatic breast cancer.Clin Breast Cancer. 2007 Oct;7(10):804-10.
  • Tolaney SM,Winer EP.Follow-up care of patients with breast cancer.Breast. 2007 Dec;16 Suppl 2:S45-50.
  • Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol. 2006 Nov 20;24(33):5330-1.